Research

Scope and Content Note

This series contains important documentation either gathered by or produced by the Assembly Office of Legislative Oversight and Analysis in its investigative work for the drug substitution law. The majority of the records are from 1977, when hearings were being conducted to determine if a generic drug law was necessary.

The series includes correspondence, memorandums, hearing testimony, conference proceedings, newspaper and journal article clippings, lists of drug prices, copies of legislation from other states, examples of drug company advertising, and various reports on the drug industry and on the safety and effectiveness of generic drugs. The evidence in the records was provided by an extremely broad range of individuals and groups involved in the manufacture, sale, and use of prescription drugs. These include physicians; pharmacists; pharmaceutical manufactures; medical organizations; local, state, and federal government officials; consumer groups; medical school faculty; and pharmaceutical laboratories.